Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holsboer

Showing results (111-120 of 1,017) with videos related to

Pageof 102
Sort By:
Praxis|December 17, 1996
[Epidemiological study of sleep disorders in patients in Swiss general practice]R Haldemann, M Good, E Holsboer-Trachsler
Psychoneuroendocrinology|January 1, 1989
Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuseU von Bardeleben, I Heuser, F Holsboer
International Journal of Psychiatry in Clinical Practice|May 11, 2016
Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysisErich Seifritz, Martin Hatzinger, Edith Holsboer-Trachsler
The Journal of Clinical Psychiatry|January 5, 2002
Met and unmet needs in the management of depressive disorder in the community and primary care: the size and breadth of the problemH U Wittchen, F Holsboer, F Jacobi
Expert Opinion on Investigational Drugs|March 15, 2011
Corticotropin releasing factor receptor antagonists for major depressive disorderMarcelo Paez-Pereda, Felix Hausch, Florian Holsboer
Schweizerische Medizinische Wochenschrift|June 15, 1991
[Eosinophilic pleuritis and hepatopathy under trimipramine therapy]M Hatzinger, R Stohler, E Holsboer-Trachsler
Psychopharmacology|August 1, 1995
Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controlsE Seifritz, U Hemmeter, L Trachsel, et al.
Brain Research|July 11, 1997
Behavioural performance in three substrains of mouse strain 129A Montkowski, M Poettig, A Mederer, et al.
Psychopharmacology|January 1, 1991
Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patientsH Wetzel, K Wiedemann, F Holsboer, et al.
Molecular and Cellular Biology|October 16, 2004
Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cellsJoëlle Rüegg, Florian Holsboer, Christoph Turck, et al.
Pageof 102

Showing results (111-120 of 1,017) with videos related to

Sort By:
Pageof 102
Praxis|December 17, 1996
[Epidemiological study of sleep disorders in patients in Swiss general practice]R Haldemann, M Good, E Holsboer-Trachsler
Psychoneuroendocrinology|January 1, 1989
Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuseU von Bardeleben, I Heuser, F Holsboer
International Journal of Psychiatry in Clinical Practice|May 11, 2016
Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysisErich Seifritz, Martin Hatzinger, Edith Holsboer-Trachsler
The Journal of Clinical Psychiatry|January 5, 2002
Met and unmet needs in the management of depressive disorder in the community and primary care: the size and breadth of the problemH U Wittchen, F Holsboer, F Jacobi
Expert Opinion on Investigational Drugs|March 15, 2011
Corticotropin releasing factor receptor antagonists for major depressive disorderMarcelo Paez-Pereda, Felix Hausch, Florian Holsboer
Schweizerische Medizinische Wochenschrift|June 15, 1991
[Eosinophilic pleuritis and hepatopathy under trimipramine therapy]M Hatzinger, R Stohler, E Holsboer-Trachsler
Psychopharmacology|August 1, 1995
Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controlsE Seifritz, U Hemmeter, L Trachsel, et al.
Brain Research|July 11, 1997
Behavioural performance in three substrains of mouse strain 129A Montkowski, M Poettig, A Mederer, et al.
Psychopharmacology|January 1, 1991
Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patientsH Wetzel, K Wiedemann, F Holsboer, et al.
Molecular and Cellular Biology|October 16, 2004
Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cellsJoëlle Rüegg, Florian Holsboer, Christoph Turck, et al.
Pageof 102